Xuewen Zhang Selected Research

Xuewen Zhang Research Topics

Disease

34	Neoplasms (Cancer) 01/2022 - 08/2010
18	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 08/2010
6	Liver Neoplasms (Liver Cancer) 01/2021 - 01/2013
5	Neoplasm Metastasis (Metastasis) 01/2021 - 12/2015
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2020 - 01/2019
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2018
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 07/2015
3	Glioma (Gliomas) 01/2018 - 09/2013
3	Carcinoma (Carcinomatosis) 01/2016 - 07/2014
2	Adenocarcinoma of Lung 01/2022 - 03/2021
2	Disease Progression 01/2021 - 07/2017
2	Carcinogenesis 01/2020 - 03/2016
2	Esophageal Squamous Cell Carcinoma 09/2019 - 01/2018
2	Pancreatic Fistula (Pancreatic Fistulas) 08/2019 - 02/2007
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 07/2017
2	Obesity 01/2018 - 01/2015
2	Liver Cirrhosis (Hepatic Cirrhosis) 02/2016 - 03/2014
1	Genomic Instability 01/2022
1	Squamous Cell Carcinoma of Head and Neck 01/2021
1	Hepatitis 01/2021
1	Infections 01/2021
1	Periapical Diseases 01/2021
1	Diabetic Nephropathies (Diabetic Nephropathy) 12/2020
1	Lymphatic Metastasis 06/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Pituitary Neoplasms (Pituitary Adenoma) 06/2018
1	Medulloblastoma 06/2018
1	Dementia (Dementias) 01/2018
1	Inflammation (Inflammations) 01/2018
1	Cognitive Dysfunction 01/2018
1	Epilepsy (Aura) 01/2018
1	Residual Neoplasm 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2017
1	Chronic Pain 01/2017
1	Cholangiocarcinoma 01/2017

Drug/Important Bio-Agent (IBA)

6	Long Noncoding RNAIBA 01/2022 - 01/2018
6	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2013
6	MicroRNAs (MicroRNA)IBA 01/2020 - 01/2015
5	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2016
3	Tumor Biomarkers (Tumor Markers)IBA 01/2022 - 05/2014
3	Biological ProductsIBA 01/2021 - 12/2015
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2018
3	CateninsIBA 01/2020 - 06/2016
2	DNA (Deoxyribonucleic Acid)IBA 06/2020 - 05/2019
2	Indicators and Reagents (Reagents)IBA 09/2019 - 07/2014
2	Cisplatin (Platino)FDA LinkGeneric 05/2019 - 01/2017
2	Immune Checkpoint InhibitorsIBA 01/2019 - 01/2018
2	Circular RNAIBA 01/2019 - 01/2019
2	VaccinesIBA 01/2019 - 07/2015
2	Transcription Factors (Transcription Factor)IBA 01/2018 - 01/2015
2	ErbB Receptors (EGF Receptor)IBA 01/2018 - 07/2017
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 07/2017
2	Insulin-Like Growth Factor I (IGF-1)IBA 02/2016 - 01/2013
2	BerberineIBA 09/2015 - 03/2014
2	Arachidonic Acid (Vitamin F)IBA 09/2015 - 08/2010
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 03/2021
1	6-methyladenineIBA 01/2021
1	Sorafenib (BAY 43-9006)FDA Link 01/2021
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2021
1	IonsIBA 01/2021
1	Photosensitizing Agents (Photosensitizers)IBA 01/2021
1	OsteopontinIBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 12/2020
1	Streptozocin (Streptozotocin)FDA Link 12/2020
1	Casein Kinase II (Casein Kinase 2)IBA 01/2020
1	Adenosine Triphosphate (ATP)IBA 01/2020
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2020
1	MethyltransferasesIBA 01/2020
1	Gemcitabine FDA Link 01/2020
1	alpha-L-Fucosidase (Fucosidase)IBA 09/2019
1	Cancer VaccinesIBA 01/2019
1	SolutionsIBA 01/2019
1	NucleotidesIBA 01/2019
1	Competitive Endogenous RNAIBA 01/2019
1	Combined VaccinesIBA 01/2019
1	Proteins (Proteins, Gene)FDA Link 06/2018
1	Peptides (Polypeptides)IBA 06/2018
1	C-Reactive ProteinIBA 01/2018
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2018
1	AlbuminsIBA 01/2018
1	WD repeat containing planar cell polarity effectorIBA 01/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2017
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2017
1	ABT-737IBA 03/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2017
1	Beclin-1IBA 03/2017
1	Antidepressive Agents (Antidepressants)IBA 01/2017

Therapy/Procedure

14	Therapeutics 01/2022 - 07/2014
4	Immunotherapy 01/2022 - 07/2015
4	Drug Therapy (Chemotherapy) 01/2021 - 01/2018
1	Photothermal Therapy 01/2021
1	Photochemotherapy (Photodynamic Therapy) 01/2021
1	Radiotherapy 01/2021
1	Pancreaticoduodenectomy 08/2019
1	Aftercare (After-Treatment) 01/2019
1	Lymph Node Excision (Lymph Node Dissection) 01/2019
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2018
1	Intravenous Administration 03/2017